GSK Pharmaceuticals' share of income utilized in India 2023, by category
GlaxoSmithKline Pharmaceuticals Limited in India spent about 38 percent of its income in material costs in fiscal year 2023. Further, 35 percent of its income was spent on operating expenses, while about seven percent was spent on exchequer contributions. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.
